SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18936575
Source:
http://linkedlifedata.com/resource/pubmed/id/18936575
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023911
,
umls-concept:C0600558
,
umls-concept:C0796679
,
umls-concept:C1274040
,
umls-concept:C2239176
pubmed:issue
4
pubmed:dateCreated
2008-10-21
pubmed:abstractText
To evaluate outcomes of downstaging patients with advanced (American liver tumor study group stage III/IV) hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE) to allow eligibility for orthotopic liver transplant (OLT).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18936575-19638902
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372354
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1528-1140
pubmed:author
pubmed-author:AndersonChristopher DCD
,
pubmed-author:BrownDaniel BDB
,
pubmed-author:ChapmanWilliam CWC
,
pubmed-author:CrippinJeffrey SJS
,
pubmed-author:DarcyMichael DMD
,
pubmed-author:LowellJeffrey AJA
,
pubmed-author:Majella DoyleM BMB
,
pubmed-author:ShenoySurendraS
,
pubmed-author:StuartJourdan EJE
,
pubmed-author:VachharajaniNeetaN
pubmed:issnType
Electronic
pubmed:volume
248
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
617-25
pubmed:dateRevised
2009-8-3
pubmed:meshHeading
pubmed-meshheading:18936575-Adult
,
pubmed-meshheading:18936575-Antineoplastic Agents
,
pubmed-meshheading:18936575-Carcinoma, Hepatocellular
,
pubmed-meshheading:18936575-Chemoembolization, Therapeutic
,
pubmed-meshheading:18936575-Dose-Response Relationship, Drug
,
pubmed-meshheading:18936575-Follow-Up Studies
,
pubmed-meshheading:18936575-Humans
,
pubmed-meshheading:18936575-Injections, Intra-Arterial
,
pubmed-meshheading:18936575-Liver Neoplasms
,
pubmed-meshheading:18936575-Liver Transplantation
,
pubmed-meshheading:18936575-Neoadjuvant Therapy
,
pubmed-meshheading:18936575-Neoplasm Staging
,
pubmed-meshheading:18936575-Preoperative Care
,
pubmed-meshheading:18936575-Retrospective Studies
,
pubmed-meshheading:18936575-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
pubmed:affiliation
Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA. chapmanw@wustl.edu
pubmed:publicationType
Journal Article
,
Comparative Study